Evidence map›Paper›PMID 42357933›Full record

ArticleImmunity, inflammation and disease2026

Development and Validation of a Nomogram to Predict Respiratory Failure With Influenza.

Mingzhen Zhao, Yi Li, Hongxiang Fu, Guanghui Jia, Xing Zhao, Yu Sun, Xingbin Li, Hongbo Zhang, Zhiwei Zhao

Abstract readValidation Study
In one paragraph

Article in Immunity, inflammation and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mingzhen ZhaoHebei Key Laboratory of Panvascular Diseases, Affiliated Hospital of Chengde Medical University, Chengde, Hebei, China.
Yi LiClinical Medicine Department, Central Research Institute for Generic Drug Preparations, Huahai Pharmaceutical Co., LTD, Linhai, Zhejiang, China.ORCID https://orcid.org/0009-0000-7955-5516
Hongxiang FuDepartment of Respiratory and Critical Care Medicine, Affiliated Hospital of Chengde Medical University, Chengde, Hebei, China.ORCID https://orcid.org/0009-0006-5109-7414
Guanghui JiaDepartment of Pathology, Affiliated Hospital of Chengde Medical University, Chengde, Hebei, China.ORCID https://orcid.org/0009-0005-8870-1622
Xing ZhaoDepartment of Pathology, Affiliated Hospital of Chengde Medical University, Chengde, Hebei, China.ORCID https://orcid.org/0009-0004-3323-9808
Yu SunDepartment of spine surgery, Affiliated Hospital of Chengde Medical University, Chengde, Hebei, China.
Xingbin LiDepartment of Respiratory and Critical Care Medicine, Hebei Chest Hospital, Shijiazhuang, Hebei, China.
Hongbo ZhangDepartment of Pathophysiology, Chengde Medical University, Chengde, Hebei, China.ORCID https://orcid.org/0009-0000-5005-6537
Zhiwei ZhaoDepartment of Respiratory and Critical Care Medicine, Affiliated Hospital of Chengde Medical University, Chengde, Hebei, China.

Funding

S&T Program of Chengde 202501A019
6 · The paper itself

Abstract

purposeInfluenza-induced respiratory failure is a severe complication of influenza that can rapidly progress to multi-organ failure or even death due to severe impairment of pulmonary ventilation or gas exchange function. Early prediction and intervention can decrease the mortality in patients with respiratory failure.

methodsA comprehensive analysis was conducted on 182 influenza-positive patients who were admitted in Affiliated Hospital of Chengde Medical University between December 2018 and May 2019. 78 patients with influenza were used for external validation at Hebei Chest Hospital. We assessed the relationship between respiratory failure and demographic characteristics, preexisting diseases, and laboratory test results in the training group. First, the variables of the nomogram of respiratory failure with influenza were selected using Least absolute shrinkage and selection operator (LASSO) and multivariate logistic regression analysis. A nomogram was developed to predict respiratory failure due to influenza. The accuracy of the proposed model was validated by utilizing the area under the receiver operating characteristic (ROC) and calibration curve. The clinical utility of the proposed model was evaluated using decision curve analysis (DCA) and clinical impact curve (CIC).

resultsA total of 182 influenza-positive patients were included, with the incidence of respiratory failure reaching 29.1% (n = 53). Risk factors contributing to respiratory failure encompassed age, tumor, influenza type, and red cell distribution width coefficient of variation (RDW.CV). Utilizing ROC and calibration curve assessment, the constructed nomogram exhibited accurate prediction of respiratory failure risk, and the AUC value in the training group was 0.79. Of the 78 patients diagnosed with influenza, 35 (accounting for 44.9%) developed respiratory failure. Using the ROC curve, the established nomogram accurately predicted the risk of respiratory failure, and the area under the curve was 0.73 in the validation cohort. Decision curve analysis and clinical impact curve verified that this model demonstrated excellent clinical utility in predicting respiratory failure among influenza patients.

conclusionA nomogram based on the expression levels of RDW.CV, influenza type, tumor, and age was an efficient model for the early identification of respiratory failure in patients with influenza. These results will be useful for guiding the prevention and treatment of respiratory failure caused by influenza.

Indexed as

Influenza, HumanNomogramsRespiratory InsufficiencyAdultAgedFemaleHumansMaleMiddle AgedRisk FactorsROC Curveageinfluenzainfluenza typenomogramRDW.CVrespiratory failuretumor

Identifiers

PMID42357933
PMCPMC13305141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.